Benzofuro[3,2-d]pyrimidines inspired from cercosporamide CaPkc1 inhibitor: Synthesis and evaluation of fluconazole susceptibility restoration

Bioorganic & Medicinal Chemistry Letters
2018.0

Abstract

In a context of growing resistance to classical antifungal therapy, the design of new drugs targeting alternative pathways is highly expected. Benzofuro[3,2-d]pyrimidine derivatives, derived from (-)-cercosporamide, were synthesized and evaluated as potential Candida albicans PKC inhibitors in the aim of restoring susceptibility to azole treatment. Co-administration assay of benzofuropyrimidinedione 23 and fluconazole highlighted a synergistic effect on inhibition of cell growth of a Candida albicans resistant strain.

Knowledge Graph

Similar Paper

Benzofuro[3,2-d]pyrimidines inspired from cercosporamide CaPkc1 inhibitor: Synthesis and evaluation of fluconazole susceptibility restoration
Bioorganic & Medicinal Chemistry Letters 2018.0
Design, synthesis, and SAR study of 3-(benzo[ d ][1,3]dioxol-5-yl)- N -benzylpropanamide as novel potent synergists against fluconazole-resistant Candida albicans
Bioorganic & Medicinal Chemistry Letters 2017.0
Synergistic antifungal effect of cyclized chalcone derivatives and fluconazole against Candida albicans
MedChemComm 2017.0
Design, synthesis and evaluation of benzoheterocycle analogues as potent antifungal agents targeting CYP51
Bioorganic & Medicinal Chemistry 2018.0
Design, synthesis and antifungal activities of novel 1,2,4-triazole derivatives
European Journal of Medicinal Chemistry 2011.0
Synthesis of new pyrrolo[2,3-d]pyrimidine derivatives as antibacterial and antifungal agents
European Journal of Medicinal Chemistry 2010.0
Design, synthesis, and structure-activity relationship studies of benzothiazole derivatives as antifungal agents
European Journal of Medicinal Chemistry 2016.0
Synthesis of novel triazole derivatives as inhibitors of cytochrome P450 14α-demethylase (CYP51)
European Journal of Medicinal Chemistry 2007.0
Design, synthesis, and biological evaluation of novel 1-(1H-1,2,4-triazole-1-yl)-2-(2,4-difluorophenyl)-3-substituted benzylamino-2-propanols
Bioorganic & Medicinal Chemistry Letters 2009.0
Fluconazole analogues containing 2H-1,4-benzothiazin-3(4H)-one or 2H-1,4-benzoxazin-3(4H)-one moieties, a novel class of anti-Candida agents
Bioorganic & Medicinal Chemistry Letters 2010.0